Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
24
Participants
Timeline
Start Date
November 30, 2013
Primary Completion Date
December 31, 2015
Study Completion Date
November 30, 2018
Conditions
Persistent Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Interventions
DRUG
Romiplostim
Trial Locations (1)
75010
Saint Louis hospital, Paris
All Listed Sponsors
lead
Assistance Publique - Hôpitaux de Paris
OTHER
NCT01980030 - Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell | Biotech Hunter | Biotech Hunter